NCT03604198 2026-02-19
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Phase 2 Active not recruiting
Corcept Therapeutics
Corcept Therapeutics
Boryung Pharmaceutical Co., Ltd